How Gilead Lost $7.8B in October Alone Post author:Sam Post published:November 2, 2017 Post category:BioPharma Gilead Sciences’ third-quarter financial results were dismal, to say the least. Source: BioSpace You Might Also Like Astellas and Universal Cells Ink $124M R&D Pact for Undisclosed Indication October 19, 2017 Lessons Learned: One-Time Leader Juno Uses Deaths to Create a Better CAR-T Formula November 12, 2017 Novartis' Sandoz Jobs on the Chopping Block February 8, 2018
